SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Director/PDMR Shareholding

8 Aug 2019 10:53

RNS Number : 4195I
Collagen Solutions PLC
08 August 2019
 

 

8 August 2019

 

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Director / PDMR Dealing

 

The Company today announces that, Jamal Rushdy, Chief Executive Officer ("CEO") of the Company, was granted options (the "Options") over 2,025,000 ordinary shares of 1 pence each in the ordinary share capital of the Company ("Shares") exercisable at a price of 3.9 pence per Share.

 

The Options will vest in three equal tranches on the first, second and third anniversaries of the date of grant. Such vesting will be conditional on his continued employment. In addition, the ability to exercise any vested Options will be dependent on achieving a closing middle market price per Share of 10 pence at any time after the date of grant and on the Company delivering sustainable positive cash flows from operations for any period of six months. All Options will lapse after 10 years from the date of grant, being 7 August 2029.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jamal Rushdy

2

Reason for the notification

 

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Collagen Solutions Plc

b)

LEI

213800IFY1CVGRGETL95

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

Ordinary shares of 1p each

 

 

 

ISIN Code: GB00B94T6Y14

b)

Nature of the transaction

Grant of options over ordinary shares of 1p each exercisable at 3.9p per share

c)

Price(s) and volume(s)

 

Price(s): Volume(s):

 

0 pence 2,025,000

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

N/A

 

 

N/A

e)

Date of the transaction

08/08/2019

f)

Place of the transaction

Outside a trading venue

 

 

For further information please contact:

 

Collagen Solutions Plc

 

Jamal Rushdy, CEO 

Via Walbrook

Hilary Spence, CFO

 

 

 

Cenkos Securities Plc (Nominated Adviser and Broker)

 

Giles Balleny

Tel: 0207 397 8900

Stephen Keys

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or collagen@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

 

 

    

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKFDPCBKKKFK
Date   Source Headline
27th Aug 20202:30 pmRNSRecommended Cash Offer for Collagen Solutions plc
19th Aug 20207:42 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 20207:48 amRNSForm 8.5 (EPT/NON-RI)
17th Aug 202012:06 pmRNSRule 2.9 Announcement
13th Aug 20201:35 pmGNWForm 8.3 - Collagen Solutions Plc
13th Aug 20209:28 amRNSForm 8.5 (EPT/NON-RI)
12th Aug 20207:00 amRNSAllotment of shares and total voting rights
10th Aug 20208:04 amRNSForm 8.5 (EPT/NON-RI)
7th Aug 20208:33 amRNSForm 8.5 (EPT/NON-RI)
5th Aug 202010:17 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202010:49 amRNSForm 8.3 - Collagen Solutions PLC
31st Jul 20207:00 amRNSFinal Results
23rd Jul 20208:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Jul 20207:41 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:54 amRNSForm 8.5 (EPT/NON-RI)
21st Jul 20207:00 amRNSTrading update
16th Jul 202010:51 amRNSForm 8.5 (EPT/NON-RI)
10th Jul 202011:37 amRNSForm 8.3 - Collagen Solutions
10th Jul 202011:15 amRNSAdditional Government Backed Loan Received
10th Jul 20209:30 amRNSForm 8.5 (EPT/NON-RI)
9th Jul 20209:34 amRNSForm 8.3 - Collagen Solutions
7th Jul 20207:00 amRNSCollagen supply agreement with NovaBone Products
6th Jul 20207:00 amRNSRealignment of Bond Repayments
1st Jul 20209:29 amRNSForm 8.5 (EPT/NON-RI)
30th Jun 20208:27 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 202012:07 pmRNSForm 8.5 (EPT/NON-RI)
23rd Jun 202011:04 amRNSForm 8.5 (EPT/NON-RI)
18th Jun 202010:04 amRNSForm 8.5 (EPT/NON-RI)
17th Jun 20209:23 amRNSForm 8.5 (EPT/NON-RI)
16th Jun 202010:06 amRNSForm 8.5 (EPT/NON-RI)
15th Jun 20207:00 amRNSTrading Update and Accounts Filing Extension
8th Jun 20208:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Jun 20209:14 amRNSForm 8.5 (EPT/NON-RI)
2nd Jun 202011:29 amRNSForm 8.5 (EPT/NON-RI)
29th May 20208:30 amRNSForm 8.5 (EPT/NON-RI)
21st May 20208:54 amRNSForm 8.5 (EPT/NON-RI)
20th May 20208:55 amRNSForm 8.5 (EPT/NON-RI)
20th May 20207:00 amRNSGovernment Backed Loan and Grant Funding Received
19th May 20204:40 pmRNSSecond Price Monitoring Extn
19th May 20204:35 pmRNSPrice Monitoring Extension
19th May 20202:06 pmRNSSecond Price Monitoring Extn
19th May 20202:00 pmRNSPrice Monitoring Extension
19th May 202011:05 amRNSSecond Price Monitoring Extn
19th May 202011:00 amRNSPrice Monitoring Extension
19th May 20208:38 amRNSForm 8.5 (EPT/NON-RI)
18th May 20207:00 amRNSStrategic Review and Formal Sale Process Update
11th May 20201:11 pmGNWForm 8.3 - Collagen Solutions Plc
4th May 20208:50 amRNSForm 8.5 (EPT/NON-RI)
30th Apr 20204:10 pmRNSForm 8.3 - Collagen Solutions plc
30th Apr 20204:02 pmRNSForm 8.3 - Collagen Solutions plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.